Histopathology · 2019 · 35 citations · 42 references
MedicineImmunologyOncologyBreast OncologyCancer ImmunologyTumor ProgressionDuctal Carcinoma In SituImmune Cell InfiltrationImmuno-oncology BiomarkersTumor AntigensTumor-associated AntigensTumor-infiltrating LymphocytesCd4+ Tumor-infiltrating LymphocytesClinicopathological CorrelationImmune Infiltration Prognostic SignaturesNegativityProgrammed Cell Death Protein 1 (Pd-1) PathwayProgrammed Death-ligand 1 BiomarkerTherapeutic Response MonitoringTherapeutic Response Prediction
Aims Host immunity influences cancer progression and therapeutic response. We investigated the potential of tumour‐infiltrating lymphocytes ( TIL s) around ductal carcinoma in situ ( DCIS ) in predicting recurrence and progression. Methods and results CD 4, CD 8, programmed cell death 1 ( PD ‐1) and programmed cell death ligand 1 (PD‐L1) expression in DCIS from 198 patients was determined by immunohistochemistry. We correlated disease‐free survival ( DFS ), clinicopathological parameters and biomarker expression with TIL density and CD 4/ CD 8 ratio. High TIL density was associated with high nuclear grade ( P < 0.001), DCIS PD‐L1 expression ( P = 0.008), TIL PD‐L1 expression ( P < 0.001), oestrogen ( ER ) negativity ( P < 0.001), progesterone ( PR ) negativity ( P < 0.001), human epidermal growth factor receptor 2 ( HER 2) positivity ( P = 0.002) and triple negativity ( P = 0.001). TIL PD‐L1 expression was associated with triple‐negative DCIS ( P = 0.028). TIL density was associated with molecular subtypes ( P < 0.001). High CD4 + T cell density was associated with high nuclear grade ( P = 0.001), microinvasion ( P = 0.037), ER negativity ( P < 0.001), PR negativity ( P = 0.001), HER 2 positivity ( P = 0.004), triple negativity ( P = 0.023) and PD‐L1 expression in TIL s ( P < 0.011). High CD 4/ CD 8 ratio was associated with PD‐L1 expression in DCIS ( P = 0.035) and TIL s ( P < 0.001). DCIS with higher TIL density disclosed worse DFS ( P = 0.012) and was affirmed with multivariate analysis [95% confidence interval ( CI ) = 1.109–2.554, hazard ratio ( HR ) = 1.683, P = 0.014]. Poorer DFS for ipsilateral invasive recurrence was found for DCIS with higher CD 4 + T cell density ( P = 0.006) or CD 4/ CD 8 ratio ( P = 0.02), confirmed by multivariate analysis for the former (95% CI = 1.369–10.196, HR = 3.736, P = 0.01) and latter (95% CI = 1.311–7.935, HR = 3.225, P = 0.011). Conclusion DCIS with higher TIL density was associated with poorer prognostic parameters and predicted recurrence, while both CD 4 + T cell density and CD 4/ CD 8 ratio were associated with both recurrence and ipsilateral invasive recurrence.
42
IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity
Vijay Shankaran, Hiroaki Ikeda, Allen T. Bruce et al. · Nature · 2001 · 2.8K citations
Life Sciences, Immunology, Oncology +12